Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00470704
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2007-05-07
Brief Title:
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
Organization:
Dana-Farber Cancer Institute